Extendicare Inc (EXETF)


Extendicare Inc. is a Canadian healthcare company focused on seniors’ care and related services. Through its subsidiaries, it operates across three segments: long-term care, home health care, and managed services. The long-term care business includes accommodation, meals, and support with daily living and continuing care for residents. Its home health care operations provide nursing care, occupational therapy, speech therapy, and assistance with everyday activities. The managed services segment includes management, consulting, and other services supplied to third parties and joint ventures. The company conducts business under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network brands. Incorporated in 1968 and based in Markham, Canada, Extendicare is listed as common stock on OTC Markets under the symbol EXET.F.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-EXET.F
$20.95
-22.6% Downside
Overvalued
Great
July 31, 2026
August 17, 2026
0.38
1.4%
August 6, 2026
29.7x
9.3x
2.1x
2.587 B
2.617 B
8.2%
98.8%
5.1
35.6%
72.3%
Valuation • Fair Value

Extendicare Inc (OTC-EXET.F) Fair Value by Valuation Model

Compare the primary fair value estimate for Extendicare Inc (OTC-EXET.F) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$20.95

Estimated downside of 22.6% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$22.97

Discounted cash flow valuation reference.

Ben Graham Formula Value

$10.16

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$18.93

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Extendicare Inc (OTC-EXET.F) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Extendicare Inc (OTC-EXET.F)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

1.258 B

Current operating scale indicator.

Revenue Forecast

1.596 B

Forward revenue estimate.

EBITDA

131 M

Current operating profitability reference.

EBITDA Forecast

177.8 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Extendicare Inc (OTC-EXET.F) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Extendicare Inc (OTC-EXET.F)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Great

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-2.42

No elevated caution signal from this screen.

Altman Z-Score

5.1

Relatively strong balance-sheet zone.

FCF / Net Income

72.3%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Extendicare Inc (OTC-EXET.F). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Extendicare Inc (OTC-EXET.F)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 6, 2026

Days to Earnings

16

Dividend Payment Date

August 17, 2026

Ex-Dividend Date

July 31, 2026

Dividend Yield

1.4%

Income yield reference.

Upcoming Dividend

0.38

Upcoming distribution amount.

Payment Type

Cash

Distribution type as reported in the data.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

35.6%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Extendicare Inc (OTC-EXET.F), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Extendicare Inc (OTC-EXET.F) Stock Forecast & Technical Outlook

Review Extendicare Inc (OTC-EXET.F) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Extendicare Inc (OTC-EXET.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Extendicare Inc (OTC-EXET.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Extendicare Inc (OTC-EXET.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Extendicare Inc (OTC-EXET.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Extendicare Inc (OTC-EXET.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Extendicare Inc (OTC-EXET.F)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for Extendicare Inc (OTC-EXET.F) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ Fast Investor Answers

Extendicare Inc (OTC-EXET.F) Stock FAQ

Quick answers about Extendicare Inc (OTC-EXET.F) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$20.95
Estimated downside 22.6%
Valuation Rating
Overvalued
Estimated downside of 22.6%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Great
Current financial-health read

The current fair value estimate for Extendicare Inc (OTC-EXET.F) is $20.95. This implies an estimated downside of 22.6% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 22.6% versus the current market price.

An analyst price target for Extendicare Inc (OTC-EXET.F) is not currently available in the latest data file.

The current financial health read for Extendicare Inc (OTC-EXET.F) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Extendicare Inc (OTC-EXET.F) is August 6, 2026.

Based on the current data, dividend yield is 1.4%, upcoming dividend amount is 0.38, ex-dividend date is July 31, 2026, payment date is August 17, 2026.

The current P/E ratio listed for Extendicare Inc (OTC-EXET.F) is 29.7x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Extendicare Inc is 2.587 B.

The current enterprise value listed for Extendicare Inc is 2.617 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Extendicare Inc is OTC-EXET.F, and the stock is listed on OTC Markets.

Extendicare Inc (OTC-EXET.F) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Extendicare Inc is 8.2%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Extendicare Inc is 98.8%. Free float helps investors understand how much of the share base is available for public trading.